Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science Angel Investors in United States in July 2025

Last updated: Jul 2025 A list of 50 angel investors that invest in Life science startups based in United states. We rank investors based on the number of investments they made in Life science companies from United states. We update this investor list every month.

Top 50 Life Science Angel Investors in United States in July 2025

Investor	Life Science United States investments
Sahin Boydas	5
bumpkins profile	4
Milad Alucozai	4
Esther Dyson	3
Darian Shirazi	3
Erik Peterson	3
Chris Gibson	3
Kevin Moore	3
Elad Gil	3
Patrick Yang	2
Nitesh Banta	2
Zach Weinberg	2
Nat Turner	2
Kathryn Haun	2
CJ Reim	2
Sridhar Iyengar	2
Joshua Elkington	2
James Hong	2
Jonathan Milner	2
David R. Walt	2
Jay Zaveri	2
Peter Harris	2
Mei Z.	2
Michael Chambers	2
Balaji Srinivasan	2
Kevin Mahaffey	2
Joe Betts-Lacroix	2
Ankit Jain	2
Craig Mundie	2
Lars Fjeldsoe-Nielsen	2
Jeff Dean	2
Patrick Collison	2
Avichal Garg	2
Sujay Jaswa	2
Alec Nielsen	2
Brian S. Cohen	2
Stephen Siegel	1
Elliott Sigal	1
Ethan Oren Perlstein	1
Alice Zhang	1
Daniel M. Bradbury	1
Paul Manning	1
Angela Jackson	1
Willard Umphrey	1
Lu Yoh-Chie	1
Jude Gomila	1
Wes Osbourn	1
Ali Shaaban	1
Jeff Raikes	1
Idris Ayodeji Bello	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Sahin Boydas is the founder of Stealth AI Startup. He previously served as the Head of Turkiye, Distributed Teams, Bootcamp, and App Ecosystem at Gusto. He attended Koç University.

Investment focus

Software, Financial Services, FinTech
Seed, Series A, Series B
United States, Mexico, Spain

Portfolio highlights

CapStack Technologies — Discover Capstack, the leading bank-to-bank marketplace driving banking digital transformation. Join the innovation wave and transform your banking experience now!
Sully.ai — Sully is deploying autonomous medical workers into healthcare organizations to address the most expensive line item in healthcare: payroll ($800b/yr in the US alone). Today, Sully's autonomous workers can perform most medical staff tasks 100x faster and 20x cheaper. From Digital Triage Nurses and Autonomous Medical Assistants to DigitalScribes and Digital Receptionists, our workers can automate patient check-in, assessments, documentation, diagnosis support, and billing that integrates with Electronic Health Records (EHRs)
Pallet — Pallet is a all-in-one logistics solution that integrates a Transportation Management System (TMS) and Warehouse Management System (WMS), to billing and reporting. Schedule a demo to see the future of modern freight businesses.

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
United States, Canada, India

Portfolio highlights

Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement

Dr. Milad Alucozai specializes in translating scientific and technological breakthroughs into scalable commercial ventures. As an Afghan-American neuroscientist, entrepreneur, and global investor, he leverages his expertise in bioengineering, computational biology, and machine learning to identify promising innovations and develop strategies fortheir successful market entry and growth. He focuses on accelerating the process of bringing groundbreaking discoveries from the lab to market, particularly in the life sciences and computationally-driven fields.Dr. Alucozai is a co-founder of Revalia Bio, which aims to create a human-centric infrastructure for drug discovery and development. By utilizing non-transplantable human organs donated for research, Revalia provides the scientific community unparalleled insights into patient biology, ultimately aiding in the development of better treatments and cures. In 2024, he partnered with The Wyss Institute at Harvard University to launch and co-host the popular "Code to Cure" series, exploring the convergence of AI, biology, and healthcare. He also contributes his expertise as a Senior Fellow in Healthcare Engineering at the Regenstrief Center.His background includes leading 70 early-stage investments as Head of Bio and Deep Tech at BoxOne Ventures, establishing the firm as a key player in North America's VC landscape. He also served as a Venture Partner at Entrepreneur First, a globally recognized talent investor backed by notable figures like Patrick and John Collison of Stripe and Reid Hoffman of LinkedIn, with a portfolio exceeding $10 billion in value. He mentors entrepreneurs across North America and Europe through channels like the Creative Destruction Lab.Throughout his operating and investing career, he has been instrumental in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. Often serving as the first investor, he guides companies from concept to successful exit and shapes business development for high-growth, venture-backed startups. His advisory work also extends to established corporations; at Accenture, he led teams advising top pharmaceutical companies on their R&D, innovation, and business development strategies. In 2020, he formally served as an External Advisor to AstraZeneca.He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a Neuroscience degree from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a visiting scholarship at the Wyss Institute at Harvard University.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, Canada, United Kingdom

Portfolio highlights

Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.

Esther Dyson - Founder @ Way to Wellville

Investment focus

Health Care, Software, Medical
Seed, Series A, Funding Round
United States, Canada, Russian Federation

Portfolio highlights

Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
Way — Way combines intuitive eating with behavior science for mindful habits. 73.5% of app users report transformed thinking post-program.
Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.

Darian Shirazi is the Managing Partner of Gradient.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Series B
United States, Germany, Canada

Portfolio highlights

Valdera — Valdera is the sourcing and procurement platform that makes it easy to buy or sell chemicals, ingredients, and raw materials. We partner with segment leaders, ranging from the world's largest CPG manufacturers to household names in the beauty industry.
Twenty (YC S23) — Building a better Salesforce, powered by the Open Source community.
Twenty — Twenty builds the modern salesforce, powered by the open source community.

Erik Peterson is the Founder at DormTrader.

Investment focus

Software, Biotechnology, SaaS
Seed, Equity Crowdfunding, Series A
United States, Canada, Algeria

Portfolio highlights

Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Investment focus

Biotechnology, Health Care, Life Science
Series A, Seed
United States, France, Switzerland

Portfolio highlights

Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
Cradle — Engineer Better Proteins Faster. AI for modern protein engineering teams.
Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Investment focus

Software, Health Care, E-Commerce
Seed, Pre-Seed, Angel
United States, India, Canada

Portfolio highlights

Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
Augmend — Create documentation and an AI assistant from any video.

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Series B
United States, United Kingdom, Israel

Portfolio highlights

Ashby — Ashby is a developer of recruitment software used for high-growth companies. It develops usable, enterprise-grade employment software that enables company leaders, recruiters, and hiring managers to run their hiring process significantly better. It was founded in 2018 and is based in San Francisco, California.
Harvey — Harvey is an artificial intelligence technology service provider.
Applied Intuition — Applied Intuition enables engineering and product development teams to safely develop, test, and deploy autonomous vehicles at scale.

Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.

Investment focus

Software, Artificial Intelligence, Health Care
Series A, Seed, Series B
United States

Portfolio highlights

Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.

Nitesh Banta is the Co-Founder & CEO at B12.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Pre-Seed
United States, Canada, India

Portfolio highlights

Vybe — Virtual Try-On & AI Styling for Fashion Stores
Protege — Protege is the platform for AI Training Data. Protege works with data holders and model builders to empower them to share training data for AI model development.
Chai Discovery — Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Investment focus

Health Care, Software, SaaS
Seed, Series A, Pre-Seed
United States, Israel, United Kingdom

Portfolio highlights

Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
Crosby — Crosby is a company with programmers from Ramp, Vanta, Meta, and Google joining attorneys.
Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.

Nat Turner is the Chairman and CEO of Collectors. He joins the Board of Directors at GameStop. Before co-founding Flatiron, Nat was Co-Founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time.Invite Media was acquired by Google in 2010. Prior to Invite Media, Nat started numerous internet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Nat earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. In his spare time, Nat is an avid golfer and tries to trick trout with fake bugs.

Investment focus

Health Care, Software, Medical
Seed, Series A, Series B
United States, China, Colombia

Portfolio highlights

CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
Collectors — Helping collectors to pursue their passion.
Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes

Katie Haun is the CEO and Founder at Haun Ventures. She was a General Partner at Andreessen Horowitz. She serves on the boards of Coinbase and HackerOne and has invested in and advised tech companies from seed to Series E stage. Katie teaches a management course at Stanford Business School and previously taught cybercrime at Stanford Law School.Previously, she spent a decade as a federal prosecutor with the U.S. Department of Justice focusing on fraud, cyber, and corporate crime alongside agencies including the SEC, FBI, and Treasury. She created the government’s first cryptocurrency task force and led investigations into the Mt. Gox hack and the corrupt agents on the Silk Road task force. She also prosecuted RICO murders, organized crime, public corruption, gangs, and money laundering, and held senior policy positions at headquarters in both the National Security Division and Attorney General’s office where her portfolio included antitrust, tax, and national security. Katie clerked for U.S. Supreme Court Justice Anthony Kennedy and is an honors graduate of Stanford Law School.

Investment focus

Blockchain, Financial Services, FinTech
Funding Round, Seed, Series A
United States, United Kingdom

Portfolio highlights

dub — The first Copy-Trading platform for stocks. Copy anyone's investments. For free. Regulated Broker-Dealer member FINRA and SIPC & FDIC insured.
Aptos — Building products, applications, and tooling on the Aptos blockchain. Bringing the benefits of decentralization to the masses.
Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.

CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.

Investment focus

E-Commerce, Robotics, Software
Series A, Seed, Series D
United States

Portfolio highlights

Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.

A serial entrepreneur in connected medical devices and wearables, Sridhar is focused on strategy and management at Elemental Machines. Previously, Sridhar was a founder and director of Misfit, makers of elegant wearable products, which was acquired by Fossil in 2015. Prior to Misfit, he founded AgaMatrix, a blood glucose monitoring company thatmade the world’s first medical device connecting directly to the iPhone. AgaMatrix shipped 15+ FDA-cleared medical products, 2B+ biosensors, 6M+ glucose meters, with partnerships with Apple, Sanofi, and Walgreens. Sridhar holds over 30 US and international patents and received his Ph.D. from Cambridge University as a Marshall Scholar. Beyond Elemental Machines, Sridhar has been known to run 13.1 miles on occasion and has sometimes been spotted on stage behind a wall of drums.

Investment focus

B2B, Life Science, Information Technology
Seed, Angel, Series A
United States

Portfolio highlights

Stedi — Automate healthcare transactions like real-time eligibility checks and claims processing with APIs that support thousands of payers.
Fuel — Slot Online Dan Judi Bola, Pkv QQ Poker Terpercaya
Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.

Joshua Elkington

Investment focus

Biopharma, Life Science, Biotechnology
Seed
United States

Portfolio highlights

Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.

James Hong

Investment focus

E-Commerce, Software, Internet
Seed, Series A, Angel
United States

Portfolio highlights

Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Spain

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Exciting Instruments — We're on a mission to simplify single-molecule fluorescence spectroscopy and make it accessible to all. Find out more about our company, our products and what makes us different now.

David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.

Investment focus

Biotechnology, Genetics, Life Science
Seed, Series A, Series B
United States

Portfolio highlights

Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.

Jay Zaveri has been serving Natural Capital as a partner since Jan 2019. He also ran venture and incubations for Social Capital, was founder of CloudOn and Future Thought Productions.

Investment focus

Health Care, Biotechnology, Information Technology
Seed, Series A, Funding Round
United States, Japan, Canada

Portfolio highlights

Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
BitClout — BitClout is a platform owned by its users. Bitcoin is decentralizing money, BitClout is decentralizing social media.
Kingdom Supercultures — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.

Peter Harris

Investment focus

Life Science, Biotechnology, Health Diagnostics
Seed
United States

Portfolio highlights

CND Life Sciences — Our suite of neurodiagnostic tests give clinicians access to objective pathological insights on diseases that are often difficult to diagnose

Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Pre-Seed, Series A
United States, United Kingdom, Singapore

Portfolio highlights

FlyMy.AI — Access cutting-edge media AI instantly. Stable, scalable, fast.
WilsonAI — WilsonAI makes the world's best AI paralegal for company's legal teams. It acts as an intelligent legal front door and assists with automating workflows while maintaining oversight.
BenchFlow — Largest benchmark hub

Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.

Investment focus

Biotechnology, Genetics, Life Science
Series A, Funding Round
United States

Portfolio highlights

Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.

Investment focus

Blockchain, Cryptocurrency, Software
Seed, Pre-Seed, Series A
United States, India, Singapore

Portfolio highlights

Aspora — Aspora help users bank seamlessly across countries, invest in diverse assets, access credit and insurance services.
Kindly MD — Kindly MD is a healthcare services and technology company that offers solutions for sleep support, pain treatment, and medication management through advanced data analytics. The company integrates mental health services, traditional medication, and plant-based alternatives to provide comprehensive, whole-person treatment. Dedicated to promoting abrighter, healthier future, Kindly MD delivers personalized care that addresses the unique needs of each patient.
Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.

Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.

Investment focus

Software, SaaS, Enterprise Software
Seed, Series A, Pre-Seed
United States, Canada, Israel

Portfolio highlights

Karman+ — Mining near Earth asteroids
Knostic — Knostic provides need-to-know access controls for Large Language Models (LLMs). Its knowledge-centric capabilities enable enterprises to expedite the deployment of LLMs and drive AI-powered innovation while maintaining value, security, and safety.
Fleet Device Management — Open-source IT and security for teams with lots of workstations and servers. (Linux, macOS, Windows, cloud, data center, OT/ICS, Chrome)

Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.

Investment focus

Life Science, Biotechnology, Pharmaceutical
Seed
United States

Portfolio highlights

VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
Spring Discovery — Giving Scientists AI Superpowers

Ankit Jain is the Founder and CEO of Infinitus Systems.

Investment focus

Health Care, Medical, Hospital
Seed, Pre-Seed
United States

Portfolio highlights

Advex AI — Advex AI assists the world's largest manufacturers in cutting costs and increasing productivity by producing highly dependable computer vision models in hours.
RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
Empower Sleep — Empower Sleep provides personalized sleep care online

Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.

Investment focus

Life Science, Chemical, Genetics
Seed, Series B, Series C
United States

Portfolio highlights

Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.

Lars Fjeldsoe-Nielsen is a Co-Founder & serves as a Partner at 2xN and General Partner at Owl Ventures. Lars Fjeldsoe-Nielsen was General Partner at Balderton Capital in London from 2015-2021 through four funds. He joined after spending a decade in Silicon Valley where he was with Uber and Dropbox.Since 2012 his venture track record includestwo IPOs (Uber, Dropbox) and 11 acquisitions.Lars joined Balderton from Uber which he joined when the company was operating in less than 20 cities. His role as Vice-President resulted in strategic alliances. Lars joined Uber from Dropbox as one of the company’s first 25 employees. As Head of Mobile, his growth deals with Samsung and other mobile OEMs helped Dropbox reach its first 100 million users. Prior to that Lars held positions at Voicesignal (acq. Nuance), Skyhook Wireless (acq. TruePosition), Ness Technologies (acq. Opentable), 3Jam (acq. Skype) and T9 Tegic (acq. AOL). More than a billion people have used the software and services distributed as a result of mobile growth partnerships led by Lars.His venture investments include Voi (Raine), Labster (A16Z), Hiya (Ericsson), Cambridge Quantum Computing (HON), Hopin (A16Z), Opensea (A16Z), Yassir (YC), Beacon (Eric Schmidt), The org (Sequoia), Octant (A16Z), Zycada (Khosla), Monarch Money (Accel) and Kukua (Tencent), Dubsmash (acq. Reddit), Tempow (acq. Google), Rahko (acq. Odyssey Therapeutics), Pocket (acq. Mozilla), Blue Bottle (acq. Nestle), Marble (acq. Caterpillar).Lars, who is Danish-Portuguese, grew up across Africa and served with the Royal Danish Guards. He holds a MBA from London Business School, where he also serves on the Board of Trustees, an MSc from Oxford University Keble College and a BSc from King’s College, London. He lives in London with his wife and three children.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Funding Round
United States, Denmark, United Kingdom

Portfolio highlights

Blue — Coming Q3. Join the waitlist here.
Quantrol Ox — Building Machine Learning Based Software for Quantum Control with a goal to maximise quantum computer uptime.
UrbanKisaan — UrbanKisaan builds vertical farms in India and sells the produce directly to consumers via subscription based app. The farms create a positive change at every step from seed to store ensuring quality and traceability. They grow fresh veggies locally produced which are grown without using soil using 95% less water. It aims to create a sustainablefuture for farming and feed the world in a way that is good for both people and the planet.It was founded in 2017 and is headquartered in Hyderabad, Andhra Pradesh, India.

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Investment focus

Artificial Intelligence, Information Technology, Software
Seed, Series A, Pre-Seed
United States, United Kingdom, Japan

Portfolio highlights

Akido Labs — At Akido, we collaborate with healthcare, government, and non-profit institutions to implement programs that tackle inequities in public health.
Emerald AI — Emerald AI creates a platform that enables AI data centers to adjust power consumption from electricity grids dynamically. This system orchestrates computing loads across data centers to bolster grid reliability. The technology aims to advance AI innovation while ensuring power affordability and electric system stability.
Parallel Bio — Using the immune system to cure disease. Parallel Bio uses a human immune system in a dish and AI to discover drugs more likely to work in patients.

Patrick Collison is the Co-Founder, CEO and Content Strategist of Stripe. He previously worked at Auctomatic as a Co-Founder. Patrick Collison attended Massachusetts Institute of Technology.

Investment focus

Software, Information Technology, Artificial Intelligence
Series A, Seed, Series C
United States, United Kingdom, India

Portfolio highlights

NewLimit — NewLimit is extending human healthspan by unlocking regenerative potential.
Cortex — Cortex makes it easy for engineering organizations to gain visibility into their services and deliver high quality software.
Pacific Fusion — Pacific Fusion was founded in 2023 with the mission to power the world with abundant, affordable, clean energy.

Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.

Investment focus

Software, Blockchain, Internet
Seed, Series A, Funding Round
United States, Canada, Mexico

Portfolio highlights

Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
Matic — The world's most advanced floor cleaner. Your home's best helper.
Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.

Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.

Investment focus

Software, FinTech, Financial Services
Seed, Series B, Series A
United States, Spain, Germany

Portfolio highlights

HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products.  e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
point.me — Search and book award flights and maximize the value of your points. Travel on points for less with point.me's flight award search tool.
Fireside — Fireside is the first interactive streaming platform that invites you to be part of the show. Co-founded by Falon Fatemi and Mark Cuban the media and entertainment networks of the future are emerging on Fireside.

Alec Nielsen is the Founder & CEO at Asimov.

Investment focus

Biotechnology, Robotics, Biopharma
Seed
United States

Portfolio highlights

LatchBio — The command center for all gene-editing bioinformatics. Analyze your CRISPR data without code in 5 minutes.
Trilobio — Biology is the future, but most lab technology is stuck in the past. Trilobio is rebuilding the biology lab from the ground up to unlock its true potential.
Lamin — Lamin Labs provides data infrastructure for biology that enables data scientists and engineers to collaborate on a single data layer for R&D teams of any size. They want to achieve for R&D data what git and GitHub did for code by integrating wet and dry laboratories, people and AI, knowledge and data, and siloed teams and organizations.Lamin Labs is headquartered in Munich, Bayern and was founded in 2022.

Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.

Investment focus

Software, SaaS, Mobile
Seed, Series A, Funding Round
United States, Israel

Portfolio highlights

Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
CourseHorse — CourseHorse is a provider of a learning platform used to centralize the learning opportunities. Its platform partners with providers of Spanish lessons, cooking courses, yoga classes, and other classes to create a single destination for people seeking personal interest education that enables people to increase ease and confidence in discovering thepath to personal enrichment.It was founded in 2011 and is headquartered in New York.
Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.

Stephen Siegel is Chairman of Global Brokerage at CBRE, the world’s largest real estate services company. In that capacity, he advises major corporations and property owners on a broad range of real estate issues. Mr. Siegel is widely regarded in commercial real estate circles as one of the industry’s most talented and prolific professionals. Hewas featured in the Urban Land Institute’s book, Leadership Legacies: Lessons Learned from Ten Real Estate Legends. Mr. Siegel was honored with Commercial Property News’ Lifetime Achievement Award and named by Crain’s as one of the 100 Most Influential Business Leaders in New York City. Prior to the merger with CBRE, as Chairman and CEO of Insignia/ESG, Mr. Siegel was largely responsible for masterminding the global expansion of the firm, nationwide as well as throughout Europe, Japan, Hong Kong, China, Thailand and Latin America. In that role, he also managed a group that completed approximately $2 billion in co-investments in a wide range of U.S. office, residential, hotel and retail real estate portfolios. Throughout his distinguished career, Mr. Siegel has arranged transactions for some of the nation’s most prominent corporate clients, among them, J.P. Morgan Chase & Co.; Sidley Austin Brown & Wood LLP; Fried Frank Harris Shriver & Jacobson LLP; Amerada Hess Corp.; Sanford C. Bernstein & Co.; Swiss Reinsurance; MetLife; Cerberus Capital Management; and Akin, Gump, Strauss, Hauer & Feld LLP. Websites featuring him: https://www.tenement.org/development_news/stephen-siegel/,

Investment focus

Medical, Life Science, Biotechnology
Seed
United States

Portfolio highlights

Gift of Life Biologics — Gift of Life Biologics powers cell and gene therapy research and commercialization with high quality, consistent, cost-effective and timely starting material.

Elliott Sigal, M.D., Ph.D. joined NEA as a Venture Partner and Senior Advisor in 2014. He is a former Executive Vice President and Director of Bristol-Myers Squibb, and served as Chief Scientific Officer and President of R&D for Bristol-Myers Squibb from 2004 until 2013. He was a principal architect of the successful Biopharma TransformationStrategy of the company. He has been instrumental in increasing R&D productivity, developing the company’s strategy in biologics and acquiring external innovation in Bristol’s String of Pearls initiative. Under his leadership, fourteen new medicines have come to market including Abilify (Schizophrenia, Bipolar Disorder), Reyataz (HIV/AIDS), Erbitux (Colon Cancer), Baraclude (Hepatitis B), Orencia (Rheumatoid Arthritis), Sprycel (Leukemia), Atripla (HIV/AIDS), Ixempra (Breast Cancer), Onglyza and Kombiglyze (Diabetes), Nulojix (Transplantation), Eliquis (Anticoagulant), Yervoy (Melanoma), and Forxiga (Diabetes). Among his accomplishments in various therapeutic areas was building BMS research into a lead position in the promising area of immuno-oncology. In 2012, Dr. Sigal was named the best R&D chief in the pharmaceutical industry by Scrip Intelligence.Dr. Sigal currently serves as a senior advisor to the healthcare team of New Enterprise Associates and also consults for select biotechnology companies. Dr. Sigal received his M.D. from the University of Chicago in 1981 and trained in Internal Medicine and Pulmonary Medicine at the University of California, San Francisco (UCSF). Prior to medical school he studied engineering at Purdue University, where he received a B.S., M.S., and Ph.D. Dr. Sigal serves as a member of the Board of Directors for the Mead Johnson Nutrition Company and the Melanoma Research Alliance.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B
United States

Portfolio highlights

Surface Oncology — Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer.
Mersana Therapeutics — Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.

Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs anddiscovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.

Investment focus

Biotechnology, Cannabis, Biopharma
Seed
United States, Canada

Portfolio highlights

Epinoma — Epinoma is a diagnostics company that focuses on the multi-omics approach to cancer monitoring. It engineers proteins that control the operating system of biology. The company was founded in 2020 and is headquartered in San Francisco, California.
BluumBio — BluumBio develops next-generation remediation technologies that clean up pollution and restore degraded ecosystems
Promakhos Therapeutics — A Boston-based biotech startup developing therapeutics.

CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, United Kingdom

Portfolio highlights

Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.

Daniel M. Bradbury is Director at Liquid Grids.

Investment focus

Life Science, Biotechnology
Series A
United States

Portfolio highlights

Alume Biosciences — Alume is a biotechnology company, developing nerve-targeted pharmaceutical agents for surgical and therapeutic use. The company's first product, ALM-488, is a fluorescently labeled peptide-dye conjugate that makes human nerves "glow," helping surgeons reduce injury to critical nerves during surgery. During surgery, inadvertentinjury to nerves leads to loss of function, including paralysis, numbness, and decreased quality of life. Alume intends to develop agents including ALM-488 to be used as an adjunct during surgery to help surgeons see nerves better compared to current visualization with white light alone. Alume's technology has the potential to improve the accuracy of nerve identification, decrease operative time, and lead to better outcomes for patients.

Paul B. Manning has served as the chairman of our board of directors since December 2017 and as a member of our board of directors since December 2015. Mr. Manning is the Chairman and Chief Executive Officer of PBM Capital Group, LLC, a private equity investment firm in the business of investing in healthcare and life-science related companies,which he founded in 2010. Prior to that, Mr. Manning founded PBM Products in 1997, a producer of infant formula and baby food, which was sold to Perrigo Corporation in 2010. Mr. Manning is a director of Dova Pharmaceuticals, Inc., a publicly traded pharmaceutical company, as well as various private companies. Mr. Manning was previously on the board of directors of Perrigo Corporation, Concordia Healthcare Corp. and AveXis, Inc. Mr. Manning received a B.S. in microbiology from the University of Massachusetts.

Investment focus

Biotechnology, Therapeutics, Medical
Series A, Series B, Post-IPO Equity
United States

Portfolio highlights

Kriya Therapeutics — Kriya is a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases. We target conditions where the underlying biology is well-understood, rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate humantissues. Our team has deep expertise in the field and includes former senior leadership from pioneering gene therapy companies and academic institutions. We use algorithmic tools, scalable infrastructure, and proprietary technology to optimize the efficacy and durability of our gene therapies – with a goal of transforming the treatment paradigm for some of the most serious and widespread diseases.
Liquidia Technologies — Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed toimprove the safety, efficacy, and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types, and routes of administration.
The Paul and Diane Manning Institute of Biotechnology — The Paul and Diane Manning Institute of Biotechnology engages in the medical research that leads to new medical treatments, including cellular therapy, gene therapy, nanotechnology and drug delivery.

Angela Jackson is an active angel investor and coach to emerging companies and entrepreneurs. Her background is in marketing/sales, strategy, fundraising and leadership. In addition to her role as the Portland/Oregon Keiretsu Forum Chapter President, Angela is also Managing Director & Fund Manager at Bridge City Ventures Portland SeedFund, Manager of the Portland State University Business Accelerator, an investor in Oregon Angel Fund and co-chair of Angel Oregon’s Consumer/Active Lifestyle investment track and serves on the company selection committee for Women’s Investment Network. Angela also advises nonprofit/social entrepreneurs and recently was an “Ask the Expert” consultant to Craigslist Foundation social entrepreneurs in New York. She is an advisor/investor with Mercy Corps’ Phoenix Fund, which helps microenterprises in third world areas succeed. Growing up in a family culture of entrepreneurship and philanthropy, she co-founded Social Venture Partners Portland with other area investors in 2001 and has launched numerous non-profit and for-profit enterprises. She held various sales/marketing roles at Auctionpay through Series A and B rounds, a period of rapid growth which earned it numerous awards including a spot on Inc. Magazine 500 fastest growing companies list. Angela loves working with people to help accelerate the success of “the big idea” and is a proud Mom to two budding entrepreneurs, ages 11 and 15.

Investment focus

Local, Internet, Software
Convertible Note, Series A
United States

Portfolio highlights

Lish — Lish specializes in corporate catering, office catering, online catering delivery, and workplace food solutions. We serve companies in Seattle & Bellevue/Eastside, including Redmond and Kirkland.
Chronicled — Automating business rule enforcement in the life sciences industry through the blockchain-powered MediLedger Network

Bill is the Chairman and Co-Founder of the Pear Tree Funds, the President of Pear Tree Investment Advisors, Inc., and the Chairman of U.S. Boston Capital Corporation. He has over 40 years of experience in the finance and investment management business.Bill holds the Chartered Financial Analyst (CFA) designation and is a member of the CFAInstitute and the Boston Security Analysts Society. He obtained his JD from Harvard Law School, an LLM in taxation from Boston University School of Law, a Masters in Personnel Administration from George Washington University, and a BS with distinction from the United States Naval Academy in Annapolis, Maryland.

Investment focus

Analytics, Life Science, Biotechnology
Seed
United States

Portfolio highlights

Thrive Bioscience — Thrive Bioscience enables quantitative biology with advanced live-cell imaging solutions, empowering researchers with data-rich, automated workflows.

Lu, the founder of Biosensors International Group Ltd, was its chairman and CEO from its inception to 2008. He retained his leadership position as chairman of the Group since January 2008. Today BIG is one of the leading medical device companies with a market cap in excess of $1.6B.

Investment focus

Medical, Health Care, Artificial Intelligence
Seed, Series A
United States

Portfolio highlights

Bot MD — Bot MD Care is an A.I. clinical chat assistant. Our A.I. integrates hospital information to provide instant answers to doctor queries and helps automates patient monitoring.
BioTrillion — We so often think of Healthcare as an industry, that we tend to forget about Healthcare as a purpose. Globally and annually, trillions of dollars are ineffectively spent on healthcare and trillions of life data points are ineffectively connected to insights about our health. There is a better way.BioTrillion is a little startup with boldambitions to more efficatiously and scalably advance Healthcare – via Digital Biomarkers.Every human generates massive amounts of life data that will unlock novel health insights & applications. BioTrillion is developing a mobile health technology platform called BioEngine4D™ – for digitally detecting dangeous drugs, digitally detecting developing diseases, and data driven drug development – by measuring data from life, analyzing it through computational advancements in machine learning and artificial intelligence, and applying it back for life.BioTrillion, Inc. is headquartered in San Francisco, CA and is reimagining Life Sciences through the fundamental principles of many sciences.Our mission is to enable consumer smart devices to empower ordinary consumers with extraordinary health insights. Advances in technology have amplified our individual capabilities in many ways, and healthcare should be no exception.Website: www.biotrillion.com Contact: contact@biotrillion.com Jobs: https://www.biotrillion.com/opportunities Application: https://biotrillion.typeform.com/to/wSvoKI

Jude Gomila is currently CEO and Founder of the startup Golden.

Investment focus

Software, Biotechnology, Information Technology
Seed, Pre-Seed, Angel
United States, United Kingdom, Canada

Portfolio highlights

Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!

Wes Osbourn

Investment focus

Chemical, Life Science, Biotechnology
Pre-Seed
United States

Portfolio highlights

Capra Biosciences — We use biology to make high performance renewable chemicals affordable and sustainable. We are revolutionizing chemical production with our patented bioreactor technology.

Ali Shaaban has been a pioneer in the digital advertising and communications industry for more than 18 years, founding the award-winning full-fledged creative digital agency Icon Creations back in 2003 when the industry was at its infancy stage. Since then, Ali Shaaban has built strong long-term relationships and a strategic network with most ofthe leading automotive brands in Egypt and the Middle East, where he established a solid track record of delivering top-notch digital products & services that stood the test of time. Driven by passion for excellence and an always-on personalized approach to satisfying his partners, Ali Shaaban is the quintessential digital partner to have on your side in the automotive industry today.His automotive portfolio includes Alfa Romeo, Bentley, BMW, Castrol, Citroën, Ferrari, Fiat, Ford, Hyundai, JAC, Jaguar, Jeep, KIA, Land Rover, Maserati, Mazda, MINI, Mitsubishi, Nissan, Peugeot, Pirelli, Renault, Seat, Subaru, Toyota, Volkswagen and more. Aside from being a digital pioneer, Ali Shaaban is also an angel investor and serial supporter of emerging innovative startups and fresh business ideas, venturing into several sectors to contribute in making a sustainable impact on the local and regional economies. His latest investments have tapped into the Fintech sector with rising companies such as Paynas (https://Paynas.com), Oxygen (https://oxygen.us/), Dfin Holding (https://www.dfinholding.com/) , and Kiwe wallet (https://kiweapp.com/) as well as the Media and AI sector with Speakol (https://speakol.com/) , NU Digital Awards (https://nudigitalawards.com/) and Nanotronics (https://nanotronics.co/ ).Ali Shaaban believes in always taking the next step forward in his extensive career, and using his core values and commanding personality as motivation, he has paved an impressive path over the years that will certainly lead towards an even more diverse and fruitful future.

Investment focus

Financial Services, FinTech, Banking
Series A, Seed, Pre-Seed
Egypt, United States, Kenya

Portfolio highlights

ImaliPay — ImaliPay is a financial health platform offering financial products to freelancers and blue collar gig workers in partnership with gig platforms.
QuadriBot — QuadriBot is an engineering company specializing in the design and development of electronics and automation technology, real-time systems and the development of IT and electronic solutions around smart transportation issues. We focus on robotics and autonomous vehicles as well as any mobile platfo.
Nanotronics Imaging — At Nanotronics we provide customized solutions for automated optical inspection, process control, and security. Learn more about what we can do for you.

Jeff Raikes is the Co-founder of the Raikes Foundation.

Investment focus

Video, AgTech, Sports
Series A, Series C, Series D
United States

Portfolio highlights

Hudl — Hudl provides video review and performance analysis tools for sports teams and athletes at every level.
Epicrop Technologies — The only company using a nature-based epigenetic approach to enhance crops, accelerating development and delivering proven results.

The 'Afropreneur' (entrepreneur with an African focus), as he self-describes, Idris Ayodeji Bello is a Partner at LoftyInc Allied Partners Limited and co-founder of The Wennovation Hub, an innovation platform based in Nigeria, that has successfully accelerated the launch of several technology start-ups in social impact sectors. He isalso a Founding Partner at Loftyinc Capital Management, owners of the Afropreneurs Fund (I&II)The 'Afropreneur' (entrepreneur with an African focus), as he self-describes, Idris Bello is a Partner at LoftyInc Allied Partners Limited and co-founder of The Wennovation Hub, an innovation platform based in Nigeria, that has successfully accelerated the launch of several technology start-ups in social impact sectors. He is also a Founding Partner at Loftyinc Capital Management, owners of the Afropreneurs Fund (I&II)A first class honors graduate of Computer Engineering from Obafemi Awolowo University, Nigeria, he has an M.Sc in Computer Science & Data Mining from the University of Houston; an MBA in Entrepreneurship & Strategy from Rice University in Houston and an M.Sc in Global Health Science from the University of Oxford, where he was a 2011 recipient of The Lord Weidenfeld Scholarship for demonstrating remarkable potential as a future leader from an emerging economy.Idris spent the greater part of a decade working at Chevron Corporation and ExxonMobil USA, where he led several large upstream technology projects across the USA and Sub-Saharan Africa. Idris has also worked with the Clinton Foundation Health Access Initiative where he played a major role in the deployment and evaluation of Swaziland’s first mobile health patient appointment reminder system as part of the country’s National AIDS Program. Listed among CNN’s Top Ten African Technology Voices, he is a Singularity University Impact Fellow, Harambe Entrepreneur Alliance Associate, Clinton Global Initiative University Fellow, MIT Global Start-up Fellow, SAP Ashoka Global Changemakers Award Winner, Dell Technology Award Winner, StartingBloc Innovation Fellow and a Nigeria Leadership Initiative Future Leader.As a leader, Idris has mentored and catalyzed scores of contributors across the growing African landscape and is an angel investor and advisor to several African startups including Andela, Flutterwave, RelianceHMO, among others. He continues to devote his efforts to the development of innovation-driven, technology-enabled social enterprises that empower the underserved and develop transformative ideas to change lives on the African continent.He spends most of his time between Lagos, Cairo, or airport lounges.

Investment focus

Software, FinTech, Mobile Apps
Angel, Seed, Pre-Seed
Nigeria, United States, Egypt

Portfolio highlights

Jem — We give employers the ability to send company-wide communications, deliver payslips, manage leave & give employees access to their earnings, via WhatsApp.
SimpliFi — SimpliFi is on a mission to democratize payments by building the leading Cards as a Service (CaaS) platform for MENA and Pakistan.
ORDA — Process orders, accept payments, connect to logistic providers, engage with your customers + more. We equip you with everything you need to grow your business.

Investors by industry